Ignite Creation Date:
2024-05-05 @ 11:58 AM
Last Modification Date:
2024-10-26 @ 9:17 AM
Study NCT ID:
NCT00195273
Status:
COMPLETED
Last Update Posted:
2010-04-28
First Post:
2005-09-12
Brief Title:
Study Evaluating Sirolimus in Kidney Transplant Recipients
Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Organization:
Wyeth is now a wholly owned subsidiary of Pfizer
Study Overview
Official Title:
A Randomized Open-Label Study Comparing the Efficacy and Safety of Sirolimus Combined With Daclizumab Mycophenolate and Corticosteroids vs Cyclosporine Mycophenolate and Corticosteroids in Renal Allograft Recipients Receiving Kidneys From Older Donors
Status:
COMPLETED
Status Verified Date:
2010-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to compare the kidney function in patients who have received a transplanted kidney and were treated with the combination of sirolimus daclizumab mycophenolate and corticosteroids versus transplanted patients treated with cyclosporine mycophenolate and corticosteroids
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None